Strategic Research

Hereditary Cancer Group

Research of the Hereditary Cancer Group at IGTP focuses on:

  • the genomics and integrative biology analysis of hereditary cancer-associated tumors
  • the generation and use of patient-derived induced pluripotent stem cells (iPSC) to model cancer syndromes such as Neurofibromatoses
  • the development and implementation of genomic techniques for the genetic diagnostics of Neurofibromatoses and related syndromes
  • the study of the molecular bases of hereditary cancer pathogenesis


Research lines of the group are:

  • Development and implementation of genomic technologies for the genetic diagnostics of hereditary cancer
  • Genomics of hereditary cancer associated tumors
  • Generation of iPSC to model hereditary cancer syndromes
  • Molecular pathogenesis of hereditary cancer syndromes



Bioinformatics expertise:

Group Leader:

Eduard Serra